Federal Register: FDA Issues Notice of Revised Guidance on Irritation and Sensitization Testing for Transdermal and Topical ANDAs
August 01, 2026
August 01, 2026
WASHINGTON, Aug. 1 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following action in the Federal Register.
* * *
The Food and Drug Administration (FDA) is announcing the availability of a revised draft guidance for industry titled "Assessing the Irritation and Sensitization Potential of Transdermal and Topical Delivery Systems for ANDAs." This revised draft guidance provides recommendations for the design a . . .
* * *
The Food and Drug Administration (FDA) is announcing the availability of a revised draft guidance for industry titled "Assessing the Irritation and Sensitization Potential of Transdermal and Topical Delivery Systems for ANDAs." This revised draft guidance provides recommendations for the design a . . .